Drugs / Sacubitril / Valsartan
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT03553303 | Oct 2018 → May 2022 | systolic heart failure | Oslo University Hospital | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Sacubitril / Valsartan | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03553303 ↗ |
| Route | Oral | “Sacubitril / Valsartan Oral Tablet” NCT03553303 ↗ |